← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 31, 2018Last known activity
Dec 15, 2024
Timeline
2010s
- Jan 1, 2016
Oxfendazole Development Group— Founded
Drugs by trial phase (4 distinct, 2 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT06565507CollaboratorPhase 2/Phase 3Dec 15, 2024
- NCT03435718Overall official - principal investigatorPhase 2Oct 31, 2018
- NCT03435718Lead sponsorPhase 2Oct 31, 2018
Details
- Founded
- Blue Bell, PA, US Jan 1, 2016
- Last known activity
- Dec 15, 2024